InvestorsObserver
×
News Home

How Does Deciphera Pharmaceuticals Inc (DCPH) Stock Rank on Wall Street?

Tuesday, January 26, 2021 01:36 PM | InvestorsObserver Analysts

Mentioned in this article

How Does Deciphera Pharmaceuticals Inc (DCPH) Stock Rank on Wall Street?

InvestorsObserver is giving Deciphera Pharmaceuticals Inc (DCPH) an Analyst Rating Rank of 60, meaning DCPH is ranked higher by analysts than 60% of stocks. The average projection by analysts for DCPH is $75.25 over the next 12 months and analyst’s classify the stock as a Strong Buy

Overall Score - 4.5
Wall Street analysts are rating DCPH a Strong Buy today. Find out what this means to you and get the rest of the rankings on DCPH!

Why are Analyst Ratings Important?

Though analyst projections should not be your only resource when determining your position on a stock, it can be a very useful tool. Analysts follow sectors/industries in-depth and tend to know how local and global conditions tend to affect demand and prices. Many analysts even participate in conference calls where they can get information to better make sense of the numbers.

InvestorsObserver averages the ratings provided by analysts and then ranks their score as a percent against the market. This allows you to compare stocks in a more comprehensive fashion than with the typical buy/sell/hold ranking.

What's Happening With Deciphera Pharmaceuticals Inc Stock Today?

Deciphera Pharmaceuticals Inc (DCPH) stock is down -2.68% while the S&P 500 is up 0.02% as of 1:33 PM on Tuesday, Jan 26. DCPH is down -$1.29 from the previous closing price of $48.07 on volume of 183,163 shares. Over the past year the S&P 500 is up 18.88% while DCPH is down -28.49%. DCPH lost -$5.00 per share the over the last 12 months.

Click Here to get the full report on Deciphera Pharmaceuticals Inc (DCPH) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App